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Abstract
Background: Some infants with congenital heart disease are at risk of in-hospital cardiac arrest. To better foresee
cardiac arrest in infants with congenital heart disease, it might be useful to continuously assess end-organ
perfusion. Near-infrared spectroscopy is a non-invasive method to continuously assess multisite regional tissue
oxygen saturation.
Case presentation: We report on two infants with duct-dependent congenital heart disease who demonstrated
a gradual change in cerebral and/or renal tissue oxygen saturation before cardiopulmonary resuscitation was
required. In both cases, other clinical parameters such as heart rate, arterial oxygen saturation and blood pressure
did not indicate that deterioration was imminent.
Conclusions: These two cases demonstrate that near-infrared spectroscopy might contribute to detecting a
deteriorating clinical condition and might therefore be helpful in averting cardiopulmonary collapse and need
for resuscitation in infants with congenital heart disease.
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Background
Some infants with congenital heart disease (CHD) are
at risk of cardiac arrest during hospitalization [1]. In-
hospital cardiac arrest occurs in approximately 2% to
6% of children admitted to paediatric intensive care
units [2, 3]. Through earlier recognition, cardiac ar-
rest may be prevented and outcomes and survival
may be improved [4].
Monitoring end-organ perfusion might help recognizing
clinical deterioration at an early stage. Near-infrared spec-
troscopy (NIRS) is a non-invasive clinical tool to continu-
ously assess multisite regional tissue oxygen saturation
(rSO2) [5]. It is based on the relative transparency of
biological young tissue (bone, skin, soft tissue) and the
ability to differentiate oxygenated hemoglobin from deoxy-
genated hemoglobin as they have distinct absorption spec-
tra. The ratio between oxygenated and total hemoglobin
represents the regional tissue oxygen saturation [6]. In in-
fants with CHD, multiple studies have investigated tissue
oxygenation at various moments during early life [7–14].
Most studies addressed the intraoperative and postopera-
tive period [7–10], but cerebral rSO2 was also assessed
preoperatively in some studies [11–14]. To our knowledge,
however, multisite tissue oxygen saturation as a predictor
of clinical deterioration in neonates with CHD has not
been described before.
We discuss two cases in which continuous monitoring
of multisite tissue oxygen saturation using NIRS indi-
cated a deteriorating clinical condition which eventually
led to cardiac arrest.
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Case presentation
Both cases in this report were part of a prospective observa-
tional cohort study (registration number NTR5233), which
was conducted between May 2014 and August 2016.
Parental informed consent was obtained in both cases. We
measured cerebral and renal rSO2 using INVOS 5100c
near-infrared spectrometers (Somanetics Corporation,
Troy, Michigan, USA) in combination with neonatal
sensors (Somanetics Corporation). Nurses were not
instructed to act on certain rSO2 values, as they were
not measured for clinical purposes.
Case 1
A boy diagnosed prenatally with pulmonary atresia with
an intact ventricular septum was born at our hospital at
a gestational age of 37.3 weeks. After birth, the patient
was admitted to the neonatal intensive care unit (NICU)
with continuous positive airway pressure (CPAP) at
seven cmH2O with a maximum of 40% O2 and infusion
with prostaglandin E1 (0.025 ug/kg/min) to maintain
pulmonary circulation. Prenatal diagnosis and ductal pa-
tency were confirmed by the pediatric cardiologist. The
patient appeared to be hemodynamically stable with
transcutaneous oxygen saturations (SpO2) between 70%
and 90% and mean arterial blood pressures between 46
and 73 mmHg. As the patient was clinically stable,
further hemodynamic parameters were not available for
this case.
Four hours after birth the boy developed three apneas.
The third apnea was followed by loss of cardiac output.
Cardiopulmonary resuscitation was initiated immediately
according to protocol. Cardiac output and heart rate,
however, remained insufficient and the boy died 6 h after
birth.
Autopsy confirmed the diagnosis of a pulmonary atre-
sia with a hypoplastic right ventricle and an intact
ventricular septum. Furthermore, autopsy revealed a
single coronary ostium, multiple ventricular-coronary
fistulas and a right ventricle dependent coronary blood
flow with bridging of a branch of the right coronary ar-
tery. There were signs of recent myocardial ischemia,
such as loss of cardiomyocytes. In addition, there was a
left-sided open ductus arteriosus between the brachioce-
phalic trunk and the pulmonary artery. Based on autopsy
findings, the most likely cause of death was considered
to be massive myocardial ischemia which is not uncom-
mon for this type of anatomy and physiology. Other
causes such as a primary intraventricular hemorrhage or
infarction cannot be ruled out completely since there
was no permission for cerebral autopsy.
Near-infrared spectroscopy case 1
Baseline cerebral and renal rSO2 were relatively low
(around 40%) and decreased rapidly approximately 40
min before cardiopulmonary resuscitation was necessary
(Fig. 1). This rapid decrease in cerebral and renal rSO2-
was probably due to a sudden decrease in arterial oxygen
saturation. All clinical parameters spontaneously recov-
ered from this incident. Cerebral rSO2, however, started
decreasing again from approximately 40% to 15% 25 min
before cardiopulmonary resuscitation was necessary, while
other hemodynamic parameters did not alarm the attend-
ing staff. Within 10 min, cerebral rSO2 had already de-
creased 50% from its original baseline value (40%) to
approximately 20%. We cannot fully explain why cerebral
rSO2 decreased before renal rSO2 and SpO2.
Case 2
A girl diagnosed prenatally with double outlet right
ventricle, transposed great arteries, a ventricular septal
defect and a hypoplastic aortic arch was born prema-
turely at our hospital at a gestational age of 34.9 weeks.
Fig. 1 The course of hemodynamic parameters and cerebral and renal oxygen saturation of the first case. SpO2, transcutaneous arterial oxygen
saturation; rSO2, regional tissue oxygen saturation
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She was admitted to the NICU with CPAP 10cmH2O
with a maximum of 40% O2 due to respiratory distress/
delayed transition. Initially, she had a wide-open ductus
arteriosus. Eighteen hours after birth her clinical condition
deteriorated with signs of a duct-dependent systemic
circulation. Therefore, prostaglandin E1 infusion was ad-
ministered (0.025 ug/kg/min) to maintain ductal patency.
During the first days after birth there was a fragile balance
between pulmonary and systemic blood flow.
At the sixth day after birth, she underwent bilateral
pulmonary banding with the intention of controlling an
ever increasing pulmonary blood flow. Peri-operatively,
hypotension was treated successfully with multiple volume
expansions and noradrenalin. Postoperatively, she was on
Bi-level Positive Airway Pressure (BiPAP)-assist and prior
to loss of output there were no clinical signs of primary re-
spiratory failure (e.g. inadvertent extubation). Arterial pH
was 7.34, arterial saturation was 90%, pCO2 was 4.8 kPa,
hemoglobin was 8.0 mmol/l and lactate was 1.5 mmol/l. At
that time, arterial blood pressure was 70/30 mmHg and she
had normal diuresis. One hour later, she suddenly devel-
oped bradycardia followed by loss of cardiac output.
Cardiopulmonary resuscitation was initiated immediately
according to protocol. Infusion with prostaglandin E1 was
transferred from a peripheral venous site to a central line
and was increased in dosage. An echocardiogram suggested
an open ductus arteriosus, revealed a poor contractility and
an inadequate cardiac output. After 40 min of cardiopul-
monary resuscitation, the sternum was re-opened. The
heart, however, was almost non-contractile and the girl died
7 days after birth.
Autopsy confirmed the diagnosis and concluded that
the lumen of the ductus arteriosus was small with a
diameter of less than three millimeter. Whether this was
too small to maintain systemic circulation and whether
prostaglandin E1 infusion was inadequate at the time of
collapse, remains unknown. Furthermore, autopsy re-
vealed an immature lung parenchyma, atelectasis of part
of the basal lobes and small inflammatory areas in both
lungs. These pulmonary findings might also have con-
tributed to the cardiopulmonary collapse.
Near-infrared spectroscopy case 2
We observed an increase in cerebral rSO2 and a de-
crease in renal rSO2 1 h before loss of output (Fig. 2).
Renal rSO2 returned to baseline, while cerebral rSO2
remained approximately 10% above baseline. This inci-
dent might have been caused by a closing ductus arterio-
sus due to insufficient Prostaglandin E1 administration
or an insufficient response to adequate Prostaglandin E1
administration. Especially the rapidly decreasing renal
rSO2 was indicative of a closing ductus arteriosus. Due
to the coarctation of the aorta, renal blood flow was
dependent on an open ductus arteriosus. The increase in
cerebral rSO2 was less easy to explain, but could be
caused by an increase in cerebral blood flow. Due to the
closing ductus arteriosus, the descending aorta might have
become narrower, leading to an increased arterial pressure
above the coarctation and subsequently increased cerebral
blood flow. Thirty minutes before cardiopulmonary resus-
citation, cerebral rSO2 started decreasing from 55% to ap-
proximately 20% and renal rSO2 decreased from 40% to
15%. Renal rSO2 decreased more rapidly compared with
cerebral rSO2 and approximately 15 min before loss of
output, renal rSO2 was less than 50% from its original
baseline value. The more rapid decrease of renal rSO2 in
comparison with cerebral rSO2 also supports the theory of
insufficient systemic circulation due to a closing ductus
arteriosus. Apart from a slowly increasing heart rate from
160 bpm to 180 bpm, hemodynamic parameters such as
Fig. 2 The course of hemodynamic parameters and cerebral and renal oxygen saturation of the second case. SpO2, transcutaneous arterial
oxygen saturation; rSO2, regional tissue oxygen saturation
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SpO2 and arterial blood pressure remained stable until
several minutes before cardiopulmonary resuscitation was
necessary (Fig. 2).
Discussion
These cases demonstrate that continuous monitoring of
multisite near-infrared spectroscopy might be helpful in
early identification of clinical deterioration in infants with
congenital heart disease. In both cases, cerebral and/or
renal rSO2 changed 30 min or more before loss of output
while other hemodynamic parameters did not indicate
that deterioration was imminent until a few minutes be-
fore cardiopulmonary resuscitation was necessary.
Cerebral rSO2 decreased 30–35% from baseline before
loss of output. McNeill et al. found that cerebral rSO2
values varied 15% or more from baseline rSO2 values
during less than 1% of the day in preterm infants [15].
Furthermore, Bernal et al. demonstrated an average
cerebral rSO2 of 77% with a standard deviation of 6.1%
within patients during the first week after birth [16]. As
a decrease of 30–35% exceeds this intra-individual vari-
ability, it seems more likely that the decrease in cerebral
rSO2 observed in the two cases was a consequence of a
deteriorating clinical condition and a subsequent reduc-
tion of cerebral perfusion, rather than the normal intra-
individual variability of NIRS.
In the current cases we did not respond to changes in
cerebral and renal rSO2, as they were measured in the
context of a prospective observational cohort study and
not for clinical purposes. In retrospect, these cases indi-
cate that large changes in cerebral and/or renal rSO2 in
infants with duct-dependent CHD should be considered a
red flag and warrant a complete check-up of the infant, in-
cluding physical examination, echocardiography and basic
blood tests. The time-interval of 15 to 30 min might give
some extra time to prevent clinical deterioration in infants
with CHD. Potential therapeutic strategies depend on the
reason of the change in cerebral and/or renal rSO2, but
could include mechanical ventilation, pharmaceutical
therapy (e.g. inotropes), volume expansion or perhaps
emergency surgery. Furthermore, it might be useful to use
predefined upper and lower limits of cerebral and renal
oxygen saturation, a principle that was recently suggested
in a large trial with preterm infants [17]. Due to the het-
erogeneity of the cardiac population, it is difficult to apply
normal ranges of cerebral and renal rSO2. In this popula-
tion it might be more useful to use limits below which
histological and biochemical changes in tissue have been
reported, i.e. below 44% [18].
Conclusions
In conclusion, in infants with duct-dependent congenital
heart disease, a significant change in cerebral and/or
renal oxygen saturation from baseline as measured by
NIRS may be an early indicator of a sudden, unexpected
clinical deterioration, which eventually could lead to car-
diac arrest and death. Increased awareness and thorough
scrutiny of the patient are required when such changes
in cerebral and/or renal oxygen saturation are observed.
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